Related references
Note: Only part of the references are listed.Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial
Venigalla Pratap Mouli et al.
HEPATOLOGY RESEARCH (2015)
Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy
N. Kimer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Pathological bacterial translocation in liver cirrhosis
Reiner Wiest et al.
JOURNAL OF HEPATOLOGY (2014)
Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure
Anne Chastre et al.
LIVER INTERNATIONAL (2014)
Reduction of Elevated Cytokine Levels in Acute/Acute-on-Chronic Liver Failure Using Super-Large Pore Albumin Dialysis Treatment: An In Vitro Study
Adrian Dominik et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2014)
A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
Barjesh Chander Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Gene expression profiling in the cerebral cortex of patients with cirrhosis with and without hepatic encephalopathy
Boris Goerg et al.
HEPATOLOGY (2013)
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy
Lokesh Jain et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
Lise Lotte Gluud et al.
METABOLIC BRAIN DISEASE (2013)
Antibiotics for the treatment of hepatic encephalopathy
Kavish R. Patidar et al.
METABOLIC BRAIN DISEASE (2013)
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
Georgios N. Kalambokis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy
Lokesh Jain et al.
DIGESTIVE AND LIVER DISEASE (2012)
Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis
Jasmohan S. Bajaj et al.
HEPATOLOGY (2012)
Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis
Ming Luo et al.
HEPATOLOGY RESEARCH (2012)
Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
Georgios N. Kalambokis et al.
LIVER INTERNATIONAL (2012)
A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
Jasmohan S. Bajaj et al.
METABOLIC BRAIN DISEASE (2012)
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Matteo Garcovich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Gut microbiota and probiotics in chronic liver diseases
Claudia Cesaro et al.
DIGESTIVE AND LIVER DISEASE (2011)
Microglia Activation in Hepatic Encephalopathy in Rats and Humans
Irina Zemtsova et al.
HEPATOLOGY (2011)
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis
D. L. Shawcross et al.
JOURNAL OF HEPATOLOGY (2011)
Probiotics for patients with hepatic encephalopathy
Richard G. McGee et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy
Praveen Sharma et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Hyperammonemia Induces Neuroinflammation That Contributes to Cognitive Impairment in Rats With Hepatic Encephalopathy
Regina Rodrigo et al.
GASTROENTEROLOGY (2010)
Ammonia and the Neutrophil in the Pathogenesis of Hepatic Encephalopathy in Cirrhosis
Debbie L. Shawcross et al.
HEPATOLOGY (2010)
The Dance of the Perivascular and Endothelial Cells: Mechanisms of Brain Response to Immune Signaling
Clifford B. Saper
NEURON (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
J. Vlachogiannakos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines
Christopher J. Henry et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Experimental models of hepatic encephalopathy: ISHEN guidelines
Roger F. Butterworth et al.
LIVER INTERNATIONAL (2009)
Ammonia impairs neutrophil phagocytic function in liver disease
Debbie I. Shawcross et al.
HEPATOLOGY (2008)
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc G. H. Besselink et al.
LANCET (2008)
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis
Tarek I. Hassanein et al.
HEPATOLOGY (2007)
Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts
Omar Cauli et al.
HEPATOLOGY (2007)
Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy
Carroll B. Leevy et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Role of ammonia and inflammation in minimal hepatic encephalopathy
D. L. Shawcross et al.
METABOLIC BRAIN DISEASE (2007)
Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory
M. Odeh
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency
I. Ilonen et al.
TRANSPLANTATION PROCEEDINGS (2006)
Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia:: A model of hepatic encephalopathy in cirrhosis
Rodrigo Jover et al.
HEPATOLOGY (2006)
Hyperammonemia increases sensitivity to LPS
Juan C. Marini et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure
Vanessa Stadlbauer et al.
CRITICAL CARE (2006)
Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model
D Hinkerohe et al.
GLIA (2005)
Lactate induces tumour necrosis factor-α, interleukin-6 and interleukin-1β release in microglial- and astroglial-enriched primary cultures
AK Andersson et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats
Lin Jia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Patients with acute on chronic liver failure display 'sepsis-like' immune paralysis
HE Wasmuth et al.
JOURNAL OF HEPATOLOGY (2005)
Serum levels of tumor necrosis factor-α correlate with severity of hepatic encephalopathy due to chronic liver failure
M Odeh et al.
LIVER INTERNATIONAL (2004)
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis
DL Shawcross et al.
JOURNAL OF HEPATOLOGY (2004)
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study
S Sen et al.
LIVER TRANSPLANTATION (2004)
Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier
D Wong et al.
EXPERIMENTAL NEUROLOGY (2004)
Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
Q Liu et al.
HEPATOLOGY (2004)
Correlation between ammonia levels and the severity of hepatic encephalopathy
JP Ong et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
J Fernandez et al.
HEPATOLOGY (2002)
Share Paper
